Učitavanje...
Development of Levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
Inhaled therapies allow for the targeted delivery of antimicrobials directly into the lungs and have been widely used in the treatment of cystic fibrosis (CF) acute pulmonary exacerbations. Nebulized levofloxacin solution (MP-376) is a novel therapy that is currently being evaluated in phase I, II,...
Spremljeno u:
| Izdano u: | Ther Adv Respir Dis |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564390/ https://ncbi.nlm.nih.gov/pubmed/24334337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465813508445 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|